For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Demineralized Allografts is tissue harvested from one individual and implanted into another of the same species. In a search for an adequate substitute for autogenous bone, cadaveric allograft has been a viable option. Structural and morselized forms are available and prepared as either fresh-frozen or freeze-dried. These grafts provide a structural framework or scaffold for host tissue to grow, hence making allograft osteoconductive. Conversely, its osteoinductive properties are mediocre at best. Upon implantation, the host is expected to experience an intricate immune response. Freezing or freeze-drying the allograft is crucial in minimizing this reaction; however, the fundamental properties of the material may be altered.
Scope of the Report:
The classification of demineralized allografts includes gel, putty and putty with chips, and the proportion of putty in 2016 is about 46%, and the proportion is in decreasing trend from 2012 to 2016.
North America region is the largest supplier of demineralized allografts, with a production market share nearly 90% in 2016. Europe is the second largest supplier of demineralized allografts, enjoying production market share nearly 8% in 2016.
Market competition is intense. Medtronic, J &J (DePuy Synthes), Zimmer, Stryker Corporation, Straumann, RTI Surgical, Surgical Esthetics are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Demineralized Allografts is expected to grow at a CAGR of roughly 7.3% over the next five years, will reach 940 million US$ in 2024, from 620 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Demineralized Allografts in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Medtronic
- J &J (DePuy Synthes)
- Zimmer
- Stryker Corporation
- Straumann
- RTI Surgical
- Surgical Esthetics
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Gel
- Putty
- Putty with Chips
- Others
Market Segment by Applications, can be divided into
- Dental
- Spine Surgery
- Trauma Surgery
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Demineralized Allografts product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Demineralized Allografts, with price, sales, revenue and global market share of Demineralized Allografts in 2017 and 2018.
Chapter 3, the Demineralized Allografts competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Demineralized Allografts breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Demineralized Allografts market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Demineralized Allografts sales channel, distributors, customers, research findings and conclusion, appendix and data source.